CAPLIN POINT LABORATORIES
Back to Income Statement
|
CAPLIN POINT LABORATORIES Last 5 Year Consolidated Net Profit History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Consolidated Net Profit | ₹641 Cr | ₹536 Cr | ₹457 Cr | ₹376 Cr | ₹300 Cr |
What is the latest Consolidated Net Profit of CAPLIN POINT LABORATORIES ?
| Year | Consolidated Net Profit |
|---|---|
| Mar2026 | ₹641 Cr |
| Mar2025 | ₹536 Cr |
| Mar2024 | ₹457 Cr |
| Mar2023 | ₹376 Cr |
| Mar2022 | ₹300 Cr |
How is Consolidated Net Profit of CAPLIN POINT LABORATORIES Trending?
| Years | Consolidated Net Profit | % Change | |
|---|---|---|---|
| Mar2026 | ₹641 Cr | 19.57 | |
| Mar2025 | ₹536 Cr | 17.33 | |
| Mar2024 | ₹457 Cr | 21.48 | |
| Mar2023 | ₹376 Cr | 25.49 | |
| Mar2022 | ₹300 Cr | - | |
Compare Consolidated Net Profit of peers of CAPLIN POINT LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| CAPLIN POINT LABORATORIES | ₹17,191.6 Cr | -4.2% | -12.9% | 14.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹418,684.0 Cr | -1.4% | -6.5% | 5.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹241,311.0 Cr | -2% | -2.7% | 40.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹173,079.0 Cr | -1.8% | -7% | 29.6% | Stock Analytics | |
| CIPLA | ₹107,528.0 Cr | 0.1% | -3% | -15.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,667.0 Cr | 0.2% | 6% | -2.4% | Stock Analytics | |
CAPLIN POINT LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| CAPLIN POINT LABORATORIES | -4.2% |
-12.9% |
14.4% |
| SENSEX | 2.7% |
-0.7% |
-10.5% |
You may also like the below Video Courses